Related Experiment Videos
Multidisciplinary cancer conferences: exploring obstacles and facilitators to their implementation
Nicole J Look Hong1, Anna R Gagliardi, Susan E Bronskill
1Departments of Health Policy Management and Evaluation and Surgery, University of Toronto; Departments of Surgical and Radiation Oncology, Sunnybrook Health Sciences Centre; and Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
Journal of Oncology Practice
|July 2, 2010
Summary
Implementing multidisciplinary cancer conferences (MCCs) in Canada requires recognizing their value, despite the effort involved. Provincial policy, administrative support, and efficient processes are key facilitators for successful MCC implementation.
Area of Science:
- Oncology
- Healthcare Management
- Health Services Research
Background:
- Multidisciplinary cancer conferences (MCCs) are crucial for optimizing cancer patient diagnosis and treatment.
- Effective implementation of MCCs is vital for improving cancer care delivery.
Purpose of the Study:
- To explore the barriers and facilitators influencing the implementation of MCCs in Canadian hospitals.
- To understand the experiences of health professionals and administrators regarding MCCs.
Main Methods:
- Qualitative exploratory study utilizing interviews and observations.
- Grounded theory principles guided the analysis of transcribed interviews from four Ontario hospitals.
Main Results:
- Thirty-seven gastrointestinal cancer MCCs were observed, with 48 interviews conducted.
- Perceived value by administrators and clinicians is the dominant theme for effective MCC implementation.
- Factors such as provincial policy, administrative support, and efficient processes influence the valuation of MCCs.
Conclusions:
- Significant variation exists in health professional enthusiasm and institutional administrative capacity for routine MCC implementation.
- A systematic implementation plan involving cancer care providers and administrators is necessary for successful MCC integration.
Related Concept Videos
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...